A breakthrough in eye health is coming from Europe, where scientists are testing a mind-bending idea: using quantum light and artificial intelligence (AI) to spot eye diseases long before symptoms appear.
The project, called SEQUOIA, is funded by the European Union’s Horizon Europe program with a €4.5 million grant. Its goal is to push eye imaging beyond what’s currently possible—helping doctors see the tiniest changes in the retina, the light-sensitive layer at the back of the eye.
The Problem with Today’s Eye Scans
Right now, doctors use Optical Coherence Tomography (OCT) to diagnose eye diseases such as glaucoma, macular degeneration, and diabetic retinopathy. OCT is like an ultrasound that uses light rather than sound to produce detailed 3D images of your retina.
But there’s a limit to how sharp those images can be. Even the best OCT machines can only see details about 1 micron wide, one hundredth the width of a human hair. The problem is that many eye diseases begin with even smaller changes at the level of individual cells. By the time vision starts to blur, damage is often already done.
Quantum Light: A New Kind of Vision
The SEQUOIA team wants to break that barrier by using quantum-entangled photons—pairs of light particles that are mysteriously connected, even if they’re far apart. When one photon changes, the other reacts instantly. This strange property could allow researchers to capture images twice as sharp as today’s scans, down to 0.5 microns.
That level of precision might let doctors detect early warning signs, such as tiny areas of swelling or thinning, before vision loss occurs.
Dr. Patrick Bowen Montague, the project’s coordinator, explained, “We’re exploring whether quantum OCT can give doctors information at smaller scales than today’s systems. It’s early research, not a finished product.”
How the Quantum Trick Works
Ordinary light used in OCT has natural limits. Quantum light behaves differently. Because entangled photons share information, they can produce much more explicit images of delicate tissues without damaging them.
The researchers are also adding a creative twist. They’re giving the light beam a corkscrew-like shape (called “orbital angular momentum”) to sharpen the edges of the images and cut down on noise. Meanwhile, AI systems in Spain and Germany are being trained to fine-tune this light in real time, making scans even clearer.
The light source behind it all is one of the most stable quantum light systems in the world, created by NKT Photonics in Denmark and PTB in Germany. It’s already being used in early lab prototypes.
Building for the Future
These prototypes scan one photon at a time. But researchers are working on faster versions that can process data continuously using a method called Fourier-domain detection, which eliminates moving parts and could make the system much faster.
This technology isn’t ready for hospitals yet, it’s still fundamental research. But if it works, the impact could be enormous.
Thinking Beyond Technology
SEQUOIA isn’t just focused on science; it’s also looking at social impact. A group of experts in eye care, AI, and medical technology is evaluating how the new imaging system could affect real people. They’re ranking factors like accuracy, speed, sustainability, and patient experience.
By asking questions like “Who benefits?” and “How can we make this technology accessible?” early on, they hope to design a tool that serves patients and impresses engineers.
A Europe-Wide Effort
This project connects some of Europe’s leading institutions:
- Nicolaus Copernicus University (Poland) – project leadership
- NKT Photonics and PTB (Germany) – building the quantum light sources
- DTU (Denmark) – testing and validating experiments
- UPV and ICFO (Spain) – developing the AI and light-control systems
- ARDITEC (Italy) – studying social and clinical impacts
The Long View
If SEQUOIA succeeds, it could change how doctors worldwide detect eye disease. Instead of waiting for vision to fade, they could spot problems at the single-cell level, even catching blindness before it starts.
The technology is still years away from being used in clinics, but the foundation is being built photon by photon and algorithm by algorithm.
In the end, it’s not just about making sharper pictures of the eye. It’s about giving people’s eyesight a head start—and maybe, one day, preventing blindness altogether.
